Literature DB >> 1594589

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

M K O'Banion1, V D Winn, D A Young.   

Abstract

The antiinflammatory glucocorticoids are potent inhibitors of cyclooxygenase, a key regulator of prostaglandin synthesis; yet, the mechanism(s) by which this occurs is not fully understood. We have cloned a 4.1-kilobase (kb) cDNA, distinct from the previously cloned cyclooxygenase (2.8 kb), that confers cyclooxygenase activity to transfected cells. The mRNA for this newly discovered cyclooxygenase is unique for its long 3' untranslated region containing many AUUUA repeats. Levels of the 4.1-kb cyclooxygenase mRNA are rapidly increased by serum or interleukin 1 beta in mouse fibroblasts and human monocytes, respectively, and decreased by glucocorticoids, whereas levels of the 2.8-kb cyclooxygenase mRNA do not change. Similar effects are seen in the presence of cycloheximide where the 4.1-kb, but not the 2.8-kb, mRNA is greatly superinduced. Thus, there are both constitutive (2.8 kb) and regulated (4.1 kb) cyclooxygenase species, the latter most likely being a major mediator of inflammation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1594589      PMCID: PMC49193          DOI: 10.1073/pnas.89.11.4888

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Isolation of the cDNA for human prostaglandin H synthase.

Authors:  T Hla; M Farrell; A Kumar; J M Bailey
Journal:  Prostaglandins       Date:  1986-12

2.  Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase).

Authors:  J P Merlie; D Fagan; J Mudd; P Needleman
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

3.  Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.

Authors:  A Raz; A Wyche; N Siegel; P Needleman
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.

Authors:  J W Han; H Sadowski; D A Young; I G Macara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

6.  Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme.

Authors:  M Hemler; W E Lands
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

7.  Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases.

Authors:  A Raz; A Wyche; P Needleman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  The CTAB-DNA precipitation method: a common mini-scale preparation of template DNA from phagemids, phages or plasmids suitable for sequencing.

Authors:  G Del Sal; G Manfioletti; C Schneider
Journal:  Biotechniques       Date:  1989-05       Impact factor: 1.993

9.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

Authors:  D L DeWitt; W L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  133 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 2.  COX in a crystal ball: current status and future promise of prostaglandin research.

Authors:  G A FitzGerald; P Loll
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

Authors:  Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

4.  Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.

Authors:  V Puigneró; J Queralt
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

5.  Fish macrophages express a cyclo-oxygenase-2 homologue after activation.

Authors:  J Zou; N F Neumann; J W Holland; M Belosevic; C Cunningham; C J Secombes; A F Rowley
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 6.  Paradigm shift in the pharmacological management of periodontal diseases.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Oral Biol       Date:  2011-11-11

Review 7.  The COXes of Danio: from mechanistic model to experimental therapeutics.

Authors:  Stephen M Prescott; H Joseph Yost
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

Review 8.  Vasoconstrictor prostanoids.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2010-03-24       Impact factor: 3.657

9.  Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.

Authors:  Alaka Mullick; Miria Elias; Penelope Harakidas; Anne Marcil; Malcolm Whiteway; Bing Ge; Thomas J Hudson; Antoine W Caron; Lucie Bourget; Serge Picard; Orce Jovcevski; Bernard Massie; David Y Thomas
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts.

Authors:  J A Gordon; L J Warnock; A A Spector
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.